Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neurocognitive Effects of Opiate Agonist Treatment (NEO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Albert Einstein College of Medicine of Yeshiva University
Sponsor:
Collaborators:
National Institute on Drug Abuse (NIDA)
Montefiore Medical Center
Fordham University
Information provided by (Responsible Party):
Julia H. Arnsten, Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier:
NCT01733693
First received: November 14, 2012
Last updated: August 4, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)